|
시장보고서
상품코드
2091262
바이오베터 시장 규모, 점유율, 성장 분석 : 분자 유형별, 질환 적응별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Bio Betters Market Size, Share, and Growth Analysis, By Molecule Type (Monoclonal Antibodies Biobetters, Insulin Biobetters), By Disease Indication (Oncology, Diabetes), By End-User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 바이오베터 시장 규모는 2024년에 583억 달러로 평가되었으며, 2025년 632억 6,000만 달러에서 2033년까지 1,214억 9,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.5%로 성장할 것으로 전망됩니다.
세계 바이오베터 시장은 비유전자 변형(비GMO)이라는 장점을 유지하면서, 가뭄 저항성이나 영양가 향상과 같은 특성을 갖춘 개량 작물을 원하는 소비자의 수요에 힘입어 농업 혁신 분야에서 중요한 위치를 차지하고 있습니다. 이 시장은 기존의 유전자 변형 작물(GMO)을 대체할 현실적인 대안으로 기능하며, 규제상의 압력과 천연 유래 개량을 선호하는 일반 소비자의 의향에 부응하고 있습니다. 기후 변화로 인한 문제가 심각해지고 식량 안보가 최우선 과제로 대두되는 가운데, 바이오베터는 틈새 시장용 제품에서 수십억 달러 규모의 활황을 보이는 산업으로 변모하고 있습니다. 주요 성장 요인으로는 기후 변화에 강한 농업 방식과 건강에 대한 관심이 높아지는 소비자 동향이 맞물린 점을 들 수 있습니다. 또한, AI의 발전으로 인해 의약품의 신속한 개선과 생산 공정의 최적화가 촉진되면서 시장에 혁명적인 변화를 가져오고 있습니다. 이에 따라 투자가 촉진되면서, 환자의 치료 성과 향상을 약속하는 차세대 바이오의약품 개발이 가속화되고 있습니다.
세계 바이오베터 시장의 성장요인
개인의 건강에 대한 관심이 높아짐에 따라, 소비자들은 화학제품에 대한 노출이 적고 영양가가 높은 바이오 유래 제품을 찾고 있습니다. 소비자들이 더 깨끗한 원료를 선호함에 따라, 제조사들은 천연 유래 바이오 성분을 함유한 제품 라인업을 확대하고 있습니다. 이러한 확대 추세는 다양한 분야에서 소비자의 수요를 높이며, 소매업체들이 바이오·베터 제품을 위한 진열 공간을 더 많이 확보하도록 유도하고 있습니다. 그 결과, 업계 각사는 변화하는 소비자의 기대에 부응하기 위해 연구 개발에 투자하고 있으며, 이를 통해 전 세계적으로 건강을 중시하는 구매 행태에 힘입어 지속적인 성장 사이클이 형성되고 있습니다. 이러한 역동성은 시장 내 혁신과 대응력을 촉진하며, 그 확장을 더욱 공고히 하고 있습니다.
세계 바이오베터 시장의 제약요인
세계 바이오베터 시장은 지역별로 상이한 복잡한 규제 환경으로 인해 큰 과제에 직면해 있습니다. 이러한 편차는 제품 승인 및 표시에 필요한 절차를 복잡하게 만들어, 개발 비용 증가와 시장 진입까지의 기간 연장으로 이어지고 있습니다. 기업은 다양한 안전 기준과 인증 요건을 이해하고 이를 준수하기 위해 막대한 자원을 투입해야 하며, 이는 혁신에 집중하는 데 방해가 될 수 있습니다. 게다가 규제 지침의 끊임없는 변화는 불확실성을 초래하여 중소기업의 시장 진입을 저해할 우려가 있으며, 그 결과 경쟁의 다양성이 저하되고 시장 전체의 성장이 저해될 것입니다. 원자재 조달에 대한 감시가 강화됨에 따라 심사 기간이 더욱 길어지고, 업무상의 복잡성이 증가하고 있습니다.
세계 바이오베터 시장의 동향
세계 바이오베터 시장에서는 정밀 공학 기술과 첨단 생명공학의 융합을 특징으로 하는, 맞춤형 의료로의 뚜렷한 추세가 나타나고 있습니다. 각 기업은 범용 제제에서 벗어나, 개별적인 건강 요구 사항, 대사 프로파일 및 구체적인 웰니스 목표에 부응하는, 표적 특이성이 매우 높은 바이오 유래 제품으로 전환하고 있습니다. 이러한 변화는 생명공학 스타트업, 학술 기관, 소비자 대상 브랜드 간의 협업 생태계를 촉진하여 혁신을 강화하는 동시에 제품 개발 주기를 가속화하고 있습니다. 효과성과 개인 맞춤화에 중점을 두는 것은 시장 역학을 재편할 뿐만 아니라, 자신의 웰니스 여정을 위해 맞춤형 솔루션을 찾는 건강 지향적인 소비자들에게 어필하는 차별화된 포지셔닝을 창출하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 바이오베터 시장 규모 : 분자 유형별
세계의 바이오베터 시장 규모 : 질환 적응증별
세계의 바이오베터 시장 규모 : 최종사용자별
세계의 바이오베터 시장 규모 : 유통 채널별
세계의 바이오베터 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.22Global Bio Betters Market size was valued at USD 58.3 Billion in 2024 and is poised to grow from USD 63.26 Billion in 2025 to USD 121.49 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).
The global Bio-betters market is emerging as a significant player in agricultural innovation, driven by consumer demand for enhanced crops that offer traits such as drought resistance and improved nutritional profiles, all while maintaining non-GMO appeal. This market serves as a viable alternative to traditional GMOs, addressing regulatory pressures and public preference for natural enhancements. As climate challenges escalate and food security becomes paramount, Bio-betters have transitioned from niche applications to a thriving multibillion-dollar industry. Key growth drivers include the intersection of climate-resilient farming practices and increasing health-conscious consumer trends. Furthermore, advancements in AI are revolutionizing the market by facilitating rapid drug refinement and optimizing production processes, ultimately fostering investment and expediting the development of next-generation biologics that promise improved patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bio Betters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bio Betters Market Segments Analysis
Global bio betters market is segmented by molecule type, disease indication, end-user, distribution channel and region. Based on molecule type, the market is segmented into Monoclonal Antibodies Biobetters, Insulin Biobetters, Erythropoietin Biobetters, G-CSF Biobetters and Others. Based on disease indication, the market is segmented into Oncology, Diabetes, Autoimmune Diseases, Neurological Disorders and Others. Based on end-user, the market is segmented into Hospitals & Specialty Clinics and Research & Academic Institutions. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Bio Betters Market
The increasing focus on personal health has led consumers to pursue bio-based products that offer lower chemical exposure and improved nutritional benefits. As people prioritize cleaner ingredient options, manufacturers are expanding their product ranges to include natural bio components. This growing trend enhances consumer demand across various sectors, prompting retailers to dedicate more shelf space to bio-better alternatives. As a result, industry players are investing in research and development to align with shifting consumer expectations, thereby creating a continuous cycle of growth driven by health-conscious purchasing behavior worldwide. This dynamic fosters innovation and responsiveness within the market, further solidifying its expansion.
Restraints in the Global Bio Betters Market
The global Bio Betters market faces significant challenges due to a complex regulatory environment that differs across various regions. This variability complicates the processes required for product approval and labeling, leading to increased developmental costs and extended timeframes to market entry. Companies often need to allocate substantial resources towards understanding and complying with diverse safety standards and authentication requirements, which can detract from their focus on innovation. Additionally, the constant evolution of regulatory guidelines introduces uncertainty that may discourage smaller enterprises from participating, resulting in reduced competitive diversity and hindering overall market growth. Increased scrutiny of ingredient sourcing further lengthens review periods and adds operational complexities.
Market Trends of the Global Bio Betters Market
The Global Bio Betters market is witnessing a significant trend towards personalized therapeutics, characterized by the integration of precision-engineering techniques and advanced biotechnologies. Companies are transitioning from generic formulations to highly targeted bio-derived products that cater to individual health needs, metabolic profiles, and specific wellness objectives. This shift is fostering collaborative ecosystems among biotech startups, academic institutions, and consumer brands, enhancing innovation and speeding up product development cycles. The emphasis on efficacy and personalization is not only reshaping market dynamics but also creating differentiated positioning that appeals to health-conscious consumers seeking tailor-made solutions for their wellness journeys.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Bio Betters Market Size by Molecule Type & CAGR (2026-2033)
- Market Overview
- Monoclonal Antibodies Biobetters
- Insulin Biobetters
- Erythropoietin Biobetters
- G-CSF Biobetters
- Others
Global Bio Betters Market Size by Disease Indication & CAGR (2026-2033)
- Market Overview
- Oncology
- Diabetes
- Autoimmune Diseases
- Neurological Disorders
- Others
Global Bio Betters Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals & Specialty Clinics
- Research & Academic Institutions
Global Bio Betters Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct
- Indirect
Global Bio Betters Market Size & CAGR (2026-2033)
- North America (Molecule Type, Disease Indication, End-User, Distribution Channel)
- US
- Canada
- Europe (Molecule Type, Disease Indication, End-User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Molecule Type, Disease Indication, End-User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Molecule Type, Disease Indication, End-User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Molecule Type, Disease Indication, End-User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Roche Holding
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Samsung Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celltrion Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sandoz Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol-Myers Squibb
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
